LBA56 Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study
| Autor: | Seufferlein, T., Uhl, W., Algül, H., Friess, H., Kornmann, M., König, A.O., Ghadimi, M., Gress, T.M., Lutz, M.P., Wille, K., Schimanski, C., Kunzmann, V., Berger, A., Schuhbaur, J., Perkhofer, L., Blome, L., Tannapfel, A., Tempero, M.A., Reinacher-Schick, A., Ettrich, T.J. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S1333-S1333 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|